Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

3.04
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
2.83
Today|||52-Week Range
10.06
-57.54%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close3.04
Today’s open3.16
Day’s range3.01 - 3.20
Volume257,715
Average volume (3 months)730,962
Market cap$128.9M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp0.000.00%
SNDXSyndax Pharmaceutica...0.000.00%
NERVMinerva Neuroscience...0.000.00%
ZGNXZogenix Inc0.000.00%
Data as of 1:00pm ET, 11/24/2017

Financials

Next reporting dateJanuary 8, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
EVP, Chief Executive &
Business Officer
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts